Monitoring health at home for adults with cystic fibrosis
Analysis of Remote Monitoring / Virtual Clinic Data in Adult Patients With Cystic Fibrosis (CF)
This study is testing if using home monitoring devices can help adults with cystic fibrosis catch health problems earlier and improve their care.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 610 (estimated) |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Sponsor | Papworth Hospital NHS Foundation Trust Government |
| Locations | 2 sites (Cambridge, Cambridgeshire and 1 other locations) |
| Trial ID | NCT06222905 on ClinicalTrials.gov |
What this trial studies
This observational study aims to evaluate the impact of home monitoring on adults with cystic fibrosis. Participants will use various home monitoring devices, including a spirometer, weighing scales, oximeter, and activity monitor, to track their health several times a week. The data collected will be linked to an app accessible by both participants and clinicians, allowing for real-time health monitoring. The study will analyze whether early detection of acute respiratory exacerbations can be achieved through this home monitoring approach, while also assessing the cost implications compared to standard care.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older with a confirmed diagnosis of cystic fibrosis who are capable of managing home monitoring.
Not a fit: Patients who are lung transplant recipients or unable to provide informed consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to earlier detection of respiratory issues in cystic fibrosis patients, potentially improving health outcomes.
How similar studies have performed: Other studies have shown promise in using remote monitoring for chronic conditions, suggesting potential success for this approach in cystic fibrosis.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion criteria 1. Diagnosis of Cystic Fibrosis based on genetic testing and/or sweat chloride levels 2. Age ≥ 18 years of age 3. Able to provide written informed consent 4. Patients who are known to be suitable for home monitoring and able to manage the process, those currently undertaking home monitoring / virtual clinics Exclusion Criteria 1. Patients unable to provide written informed consent 2. Patients unwilling to consent to their link anonymized data from home monitoring / virtual clinics being used for research 3. Lung transplant recipients
Where this trial is running
Cambridge, Cambridgeshire and 1 other locations
- Royal Papworth Hospital — Cambridge, Cambridgeshire, United Kingdom (Recruiting)
- Royal Papworth Hospital NHS Foundation Trust — Cambridge, Cambridgeshire, United Kingdom (Recruiting)
Study contacts
- Principal investigator: Andres Floto — Royal Papworth Hospital
- Study coordinator: Lucy Gale
- Email: lucy.gale1@nhs.net
- Phone: 01223638480
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.